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BACKGROUND: The evidence on the relationship between coffee intake and cancer of the oral cavity and oesophagus is conflicting and
few follow-up studies have been done.
Methods: A total of 389624 men and women 40–45 years who participated in a national survey programme were followed with
respect to cancer for an average of 14.4 years by linkage to the Cancer Registry of Norway. Coffee consumption at baseline was
reported as a categorical variable (0 or o1 cup, 1–4, 5–8, 9þ cups per day).
RESULTS: Altogether 450 squamous oral or oesophageal cancers were registered during follow-up. The adjusted hazard ratios with
1–4 cups per day as reference were 1.01 (95% confidence interval: 0.70, 1.47), 1.16 (0.93, 1.45) and 0.96 (0.71, 1.14) for 0 or o1
cup, 5–8 and 9þ cups per day, respectively. Stratification by sex, type of coffee, smoking status and dividing the end point into oral
and oesophageal cancers gave heterogeneous and non-significant estimates.
CONCLUSION: This study does not support an inverse relationship between coffee intake and incidence of cancer in the mouth or
oesophagus, but cannot exclude a weak inverse relationship.
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The evidence regarding the effect of coffee on cancer of the mouth,
pharynx and larynx is judged as ‘limited – no conclusion’ (World
Cancer Research Fund, 2007). Coffee is not mentioned among
the food and nutritional factors that may modify the risk of cancer
in the oesophagus. However, high-temperature drinks are judged
as ‘limited – suggestive’ in increasing the risk (World Cancer
Research Fund, 2007). A recent prospective study from Japan
found an inverse relationship between coffee dose and the risk of
oral, pharyngeal and oesophageal cancers (Naganuma et al, 2008).
One prospective study from Norway found no relationship,
whereas another study found an inverse relationship between
coffee consumption and incidence of cancer in the buccal cavity
and pharynx (Jacobsen et al, 1986; Stensvold and Jacobsen, 1994).
The Japanese and the two Norwegian studies are the only
prospective studies on this subject as far as we know.
Some case–control studies have found an inverse relationship
(Tavani et al, 2003; Rodriguez et al, 2004), but not all (La Vecchia
et al, 1989; Pintos et al, 1994). An update on coffee and cancer risk
concluded that ‘epidemiological data indicate an inverse relation
between coffee, liver and probably oral and oesophageal cancers’
(La Vecchia and Tavani, 2007). A recent pooled analysis of nine
case–control studies of head and neck cancers with 5139 cases
concluded with a support of the hypothesis of an inverse
association between caffeinated coffee drinking and risk of cancer
of the oral cavity and pharynx (Galeone et al, 2010a). So did a
meta-analysis by Turati et al (2011) based on 2633 cases. These
cancers are serious with a 5-year relative survival of o10% for
oesophageal cancer and around 50% for oral cancer in Norway
(Cancer Registry of Norway, 2010). It is thus of great importance
to obtain evidence of preventive measures of these cancers.
We conducted a prospective study, including close to 400000
participants aged 40–45 years.
MATERIALS AND METHODS
Study population
During 1985–1999, a cardiovascular survey programme was
carried out in Norway. All men and women aged 40–42 years
were invited. All counties, except for the capital Oslo, were visited
every third year and each time a new cohort aged 40–42 was
invited. In a few counties, a sample of people aged 43–45 years was
invited. The attendance rate declined from close to 80% in the
beginning down to nearly 60% at the end. Altogether 395291
individuals participated in the surveys. We excluded 4603 who
were registered as having cancer before attending the screening.
In addition, 1064 did not answer the coffee questions, leaving
389624 for analysis. Of these, 130593 (33%) answered the question
on alcohol, which was introduced in 1994.
Variables
The study protocol was the same throughout the study period.
Height and weight were measured to the nearest centimetre
and half kilo. Underwear, stockings and trousers were allowed, but
not shoes.
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yThe questionnaire included questions on coffee consumption,
smoking habits, cardiovascular history, diabetes history and
physical activity. From 1994, questions about alcohol consumption
were included and from 1997, a question about the consumption of
fruit and vegetables was included. The questions about coffee were
‘How many cups of coffee do you usually drink a day?’ with preset
categories; none or o1, 1–4, 5–8, 9þ cups. ‘What type of coffee
do you usually drink each day?’ with preset categories; boiled
coffee, filtered coffee, instant coffee, decaffeinated coffee and don’t
drink coffee. From 1994, the questions were changed to ‘How many
cups of boiled coffee do you usually drink a day?’ and ‘How many
cups of other types of coffee do you usually drink a day?’ The
participants filled in the actual number of cups. We categorised the
number of cups according to the preset categories 0 or o1, 1–4,
5–8 and 9þ cups per day, coded as 1, 2, 3, 4, respectively. We then
categorised the subjects into drinkers of boiled coffee and drinkers
of other types. Note that drinkers of boiled coffee may also drink
other types, whereas the ‘other types’ group does not include any
boiled coffee drinkers.
The question on physical activity during leisure time had four
alternatives from sedentary to intensive. However, during 1994–
1997 (B22% of the study population), we asked about the number
of hours of strenuous activity (sweating/out of breath) with four
categories from none to 3þ hours per week. We have defined
those in the lowest category of either question as sedentary.
The questions on alcohol read ‘How many glasses of (1) beer
(2) wine (3) spirits do you usually drink every 2 weeks?’. For each
type, the actual number of glasses was filled in. In addition, there
was a question on teetotalism (yes, no). In Norway, an alcohol unit
is defined as 15ml (12.8g). This corresponds to a bottle (33cl) of
beer (4.5%), a glass (15cl) of wine (12.0%) and a small glass (4cl)
of spirits (40%). We estimated the number of units per month by
adding the number of glasses stated and multiplying by 2. We
defined the categories as follows: (1) teetotaller, (2) not teetotaller,
but 0 units per month, (3) o10 units per months and (4) 10þ
units per month.
We defined five smoking categories as follows: (1) never
smokers, (2) ex-smokers, (3) 1–19 cigarettes per day, (4) 20þ
cigarettes per day and (5) others. People who smoked a pipe or
cigars, but not cigarettes, made up the ‘others’ group.
Body mass index was categorised as o20, 20–24, 25–29, 30þ
kgm
–2.
Information on educational level was collected from a national
register in Statistics Norway by linkage as described beneath (end
points). High education was defined as 13 or more years of
education.
Statistical analysis
The participants accrued person years from the date of their
examination during the national survey to the date of first cancer,
death, emigration or 31 December 2007.
Hazard ratios were estimated by Cox proportional hazards
regressions with person years as the time variable. Smoking, body
mass index, alcohol consumption and coffee intake were entered as
dummy variables, according to the abovementioned categorisation
and with never smokers, o20kgm
–2, teetotallers and 1–4 cups
per day, respectively, as reference categories. When testing for
trend, coffee was entered as a continuous variable coded as 1, 2,
3, 4. Equality of means or proportions across coffee groups was
tested by analysis of variance or by w
2 statistics from contingency
tables, respectively. P-values o0.05 were considered statistically
significant and all tests were two sided.
This study has a 90% power to detect a hazard ratio of 0.83
between two adjacent coffee groups. When taking the correlation
between the coffee and smoking groups into account, the power is
reduced to 87% when smoking is adjusted for. The power is 90% to
detect a hazard ratio of 0.77 on half the study population.
End points
Information on cancer was taken from the Cancer Registry of
Norway by linkage using the encrypted personal identification
number attributed to each inhabitant in Norway.
We used malignant neoplasm of buccal cavity or oesophagus
(ICD-7 140–148, 150) as end point, restricted to squamous cell
carcinoma (morphology codes 8050–8080, International Classifi-
cation of Diseases for Oncology, Edition 3), which made up 93% of
all cancers in mouth and oesophagus. We also did separate
analyses for squamous cancers in the oesophagus (ICD-7 150) and
in the mouth (ICD-7 140–148).
Altogether 450 people had cancer of the buccal cavity or
oesophagus, distributed as cancer of lip (n¼61), tongue (n¼85),
salivary gland (n¼33), floor of mouth (n¼28), other parts of
mouth or unspecified (n¼36), oral mesopharynx (n¼88),
nasopharynx (n¼5), hypopharynx (n¼16), pharynx unspecified
(n¼2) and oesophagus (n¼96). In multivariate analyses, there
were 446 end points due to missing information on confounders in
some individuals. In the subgroup who had answered the alcohol
questions, there were 75 end points, 74 in multivariate analyses.
RESULTS
Table 1 shows baseline characteristics of age, smoking habits, body
mass index and for the relevant subgroup, alcohol intake. Men
were in the majority in the highest coffee consumption group and
in the minority in the other coffee groups. About 20% smoked in
the lowest coffee dose group increasing to 470% among people
who drank nine or more cups per day. The proportion of boiled
coffee use and daily smoking increased with the number of cups,
whereas the proportion with high education decreased to less than
half in the highest as compared with the lowest coffee dose group.
The proportion of physically active people was also lowest in the
highest coffee dose group. Alcohol consumption did not vary









N 41454 153376 150724 44070
Age (mean) 41.3 41.4 41.4 41.4
Men, % 46.0 43.4 49.4 61.1
Boiled, % 4.4 26.4 31.0 36.3
High education, % 30.4 28.7 20.4 12.1
Physically active, % 78.3 81.6 78.4 69.7
Smoking, %
Never 45.9 39.3 25.2 13.7
Ex 34.7 33.0 25.4 14.7
o20 cig 14.5 23.0 37.1 40.7
20+ cig 4.6 4.4 11.5 30.5
Smoke, not cig 0.2 0.3 0.5 0.5
BMI (kgm
–2), %
o20 5.3 4.7 4.5 4.5
20–24 49.7 52.0 49.4 46.2
25–29 33.5 34.4 37.4 39.2
30+ 11.5 8.8 8.6 10.1
Alcohol, %
N (with info on alcohol) 14812 48445 49361 17975
Teetotallers 19.3 8.6 6.6 6.0
0 units per month 29.0 20.3 21.6 24.4
o10 units per month 27.3 34.9 31.5 28.1
10+ units per month 24.0 36.0 40.2 41.4
Abbreviations: BMI¼body mass index; cig¼cigarettes. Men and women 40–45
years.
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ymuch in the three upper coffee groups, whereas the consumption
of alcohol was less in the 0 or o1 cup group.
The hazard ratios varied between 0.96 and 1.16 in the coffee
groups with no distinct trend (Table 2). Stratification by sex,
smoking and type of coffee revealed no distinct pattern. It is noted,
however, that there is a positive trend among the non-smokers
with a P-value for the trend slightly smaller than 0.05. However,
this could be expected by chance when doing multiple testing, and
testing for interaction between smoking (yes/no) and coffee
consumption gave no significance (P¼0.08).
The lack of a consistent trend with coffee dose persisted when
specifically using oral and oesophageal cancers as end point
(Table 3).
Additional adjustment for alcohol in the subsample with
information on alcohol consumption (the 33% of the study
population, which entered in the period 1994–1999) had virtually
no impact on the coffee–cancer association (Table 4).
Information on fruit and vegetables was available for 17% of the
study population (those who were examined in 1997–1999). The
proportion who consumed fruit/vegetables daily varied marginally
between the three lowest coffee dose groups, whereas the
proportion in the 9þ cups was lower in both men and women
(data not shown).
DISCUSSION
In this large study of middle-aged men and women, we found no
relationship between coffee dose and cancer of the buccal cavity,
pharynx and oesophagus.
There have been some studies on this topic, but with ambiguous
results. In a recent update from 13 studies, La Vecchia and Tavani
(2007) reported that 12 of these found no association between
coffee intake and cancers of the oral cavity, pharynx and
oesophagus.
On the other hand, in a short report from two case–control
studies, it was concluded that ‘coffee may decrease the risk of oral/
pharyngeal and esophageal cancer’. A coffee dose of 3þ cups was
compared with o1 cup per day (Tavani et al, 2003).
Cancer in the oral cavity and oesophagus is a rare disease in
young people. Rodriguez et al (2004) found that high consumption
of coffee (3þ cups per day) was inversely related to risk of oral
and pharyngeal cancer below age 46. Interestingly, this study
revealed an inverse relationship with body mass index, but as the
authors state, this may be due to reverse causation.
A recent prospective study from Japan found 50% lower risk for
oral, pharyngeal and oesophageal cancers for users of X1 cup per
day as compared with no users (Naganuma et al, 2008). The
Table 2 Adjusted HR
a with 95% CI of squamous oral–oesophageal cancer by daily coffee consumption
0, o1 cup 1–4 cups 5–8 cups 9+ cups HR per 1 unit P-trend
All
Cases 35 139 207 69
Pyrs 580385 2213629 2184454 619489
HR 1.01 Ref 1.16 0.96 1.02 0.79
95% CI (0.70, 1.47) (0.93, 1.45) (0.71, 1.31) (0.90, 1.14)
Men
Cases 30 87 148 60
Pyrs 271137 975204 1089176 379842
HR 1.33 Ref 1.24 1.11 1.01 0.88
95% CI (0.88, 2.02) (0.95, 1.63) (0.78, 1.58) (0.88, 1.16)
Women
Cases 5 52 59 9
Pyrs 309248 1238424 1095277 239647
HR 0.42 Ref 1.04 0.57 1.03 0.78
95% CI (0.17, 1.05) (0.71, 1.53) (0.27, 1.20) (0.82, 1.30)
Non-smokers
Cases 18 77 66 15
Pyrs 466172 1586749 1091824 172339
HR 0.78 Ref 1.14 1.51 1.22 0.043
95% CI (0.47, 1.30) (0.82, 1.59) (0.87, 2.64) (1.01, 1.47)
Smokers
Cases 17 62 141 54
Pyrs 114 212 626880 1092630 447150
HR 1.43 Ref 1.19 0.87 0.91 0.24
95% CI (0.84, 2.45) (0.88, 1.61) (0.60, 1.27) (0.79, 1.06)
Boiled coffee
Cases 2 39 74 32
Pyrs 30669 611247 703807 231139
HR 0.88 Ref 1.26 1.17 1.10 0.40
95% CI (0.21, 3.64) (0.85, 1.87) (0.71, 1.92) (0.88, 1.39)
Other coffee
Cases 33 100 133 37
Pyrs 549715 1602381 1480646 388350
HR 1.01 Ref 1.11 0.83 0.98 0.73
95% CI (0.68, 1.51) (0.85, 1.54) (0.56, 1.24) (0.85, 1.12)
Abbreviations: CI¼confidence interval; HR¼hazard ratios; Pyrs¼person years.
aAdjusted for sex (except when stratified by sex), daily smoking (except in non-smokers), body
mass index and education.
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yexposure groups in that study (never use, occasional use and X1
cup per day) are practically non-overlapping with the exposure
groups in our study. The Japanese study compares low dose with
no dose, whereas our study compares high dose with low dose.
Quite recently, a study of pooled individual-level data from nine
case–control studies was published (Galeone et al, 2010a). The
findings supported the hypothesis of an inverse association
between caffeinated coffee drinking and oral and pharyngeal
cancer. The odds ratio of 44 cups per day vs zero cups per day
varied between 0.5 and 0.7 in various strata of geography,
education, tobacco consumption, alcohol consumption and
vegetable and fruit intake, which are quite consistent results. The
authors claimed that recall bias of coffee consumption was not
likely, as coffee consumption was not known to be related to head
and neck cancers. On the other hand, recall bias on smoking habits
and alcohol intake may well have taken place. It is hard to assess
the impact on the risk estimates of recall bias of confounders. A
meta-analysis by Turati et al (2011) on eight case–control studies
and one observational study found a relative risk of 0.64
comparing the highest and lowest coffee consumption groups.
There are many examples that case–control studies more
readily reveal associations than prospective studies do. One reason
is that case–control studies are more likely to be encumbered with
bias such as recall bias. Besides the Japanese study, we know of two
prospective studies, both from Norway (Jacobsen et al, 1986;
Stensvold and Jacobsen, 1994). None of these consistently
supported an inverse association, but Stensvold and Jacobsen
(1994) reported a borderline significant inverse association with
cancer of the buccal cavity and pharynx in men.
Regarding the tendency for different findings in case–control
and prospective studies, another example is the relation between
coffee consumption and colorectal cancer. One meta-analysis of
case–control studies suggested a favourable moderate effect of
coffee consumption on colorectal cancer (Galeone et al, 2010b).
Another meta-analysis on prospective studies found no relation-
ship (Je et al, 2009). On the other hand, there was a slight
suggestion of an inverse association in some of the studies, and
this suggestion was stronger in studies with shorter follow-up. The
upshot might be reverse causation since people with disease
symptoms might reduce their coffee consumption. We checked
this possibility in our study population by estimating hazard ratios
based on 5 years follow-up (77 cases). There was no tendency of
lower hazard ratios (data not shown).
Our study is by far the largest prospective study as measured by
the number at risk. Potential confounders have been taken into
account and the follow-up is nearly complete using the National
Cancer Registry and the Cause of Death Registry as end point
registries. The Cancer Registry of Norway reports a completeness
of 98.8% for the period 2001–2005 except for haematological
malignancies and cancer of the central nervous system. For the
period 2003–2007, 97.6% of the cancers in mouth and pharynx
(ICD-10 C10-C14) and 95.0% of the oesophageal cancers (ICD-10
C15) were morphologically verified. (Cancer Registry of Norway,
2010).
Limitations
We have to keep in mind that this data set is from a systematic
screening over a 15-year period with a primary focus on
cardiovascular disease.
We have no information about what people added to the coffee,
such as milk or sugar. These ingredients have not been linked to
oral–oesophageal cancers, but milk might influence the tempera-
ture of the coffee that is consumed in a favourable way with regard
to the risk of oesophageal cancer. However, the Expert Report
Panel judged the evidence of high-temperature drinks as a cause of
oesophageal cancer as limited (World Cancer Research Fund,
2007).
Another weakness is that we only have information on alcohol
consumption in a subgroup and on fruit and vegetable consump-
tion in an even smaller subgroup. These questions were introduced
when the programme had been running for 9 and 12 years,
respectively. The counties were visited every third year, when new
cohorts of 40–42-year olds were invited. This means that the
subgroups with information on alcohol and fruit/vegetables were
born later and represent a minor selection of counties compared
with the total study population, but there is no reason to believe
that the distribution of alcohol dose and the prevalence of daily use
of fruit or vegetables in the subgroups deviated from that in the
total study population. Alcohol and fruit/vegetables have both
been related to cancer risk; fruit and vegetables in a favourable way
(La Vecchia et al, 1997), and alcohol in an unfavourable way
(World Cancer research fund). Our data from the subgroups with
fruit/vegetables and alcohol indicate that these variables were not
important confounders in our study. Nevertheless, the fact remains
Table 3 Adjusted HR
a with 95% CI of subtypes of squamous oral–oesophageal cancer by daily coffee consumption
0, o1 cup 1–4 cups 5–8 cups 9+ cups HR per 1 unit P-trend
Buccal
Cases 29 114 158 53
Pyrs 580385 2213629 2184454 619489
HR 1.03 Ref 1.12 0.96 1.01 0.92
95% CI (0.68, 1.55) (0.88, 1.44) (0.68, 1.36) (0.88, 1.15)
Oesophagus
Cases 6 25 49 16
Pyrs 580385 2 213 629 2184454 619489
HR 0.93 Ref 1.34 0.97 1.06 0.67
95% CI (0.38, 2.26) (0.82, 2.18) (0.50, 1.88) (0.82, 1.36)
Abbreviations: CI¼confidence interval; HR¼hazard ratios; Pyrs¼person years.
aAdjusted for sex, daily smoking, body mass index and education.
Table 4 Adjusted HR with 95% CI of squamous oral–oesophageal
cancer by daily coffee consumption in the subgroup where questions on
alcohol were included




a Ref 0.98 0.93
95% CI — (0.59, 1.61)
HR with alcohol units
b Ref 0.98 0.94
95% CI — (0.59, 1.62)
Abbreviations: CI¼confidence interval; HR¼hazard ratios; Pyrs¼person years.
aAdjusted for sex, daily smoking, body mass index and education.
bAdjusted for sex,
daily smoking, body mass index, education and alcohol consumption.
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ythat we have not been able to adjust the entire study population for
alcohol consumption and dietary intake of fruit and vegetables.
A proportion of smokers may have stopped smoking during
follow-up. The official surveys show that the smoking prevalence
in ages 15–74 years has declined from 35% in 1991 to 25% in 2006
(Statistics Norway, 2011). However, this would not influence the
adjusted estimates of the coffee–cancer association unless
smoking cessation depended on baseline coffee consumption or
affected later coffee consumption.
As mentioned, we do not know what people put in their coffee.
Other factors that may vary between studies are type of coffee (in
Norway Coffee Arabica L), ways of preparing the coffee and size of
cup. However, stratified analyses give no reason to believe that
differences in the type of coffee or brewing methods can explain
the conflicting results between our study and the majority of case–
control studies. The power of our study was high to detect a hazard
ratio of 0.8 between two adjacent coffee groups. But we cannot
exclude a weak inverse relationship.
This study does not support an inverse relationship between
coffee intake and cancers in the buccal cavity, pharynx and
oesophagus.
Conflict of interest
The authors declare no conflict of interest.
REFERENCES
Cancer Registry of Norway (2010) Cancer in Norway 2008 – Cancer
Incidence, Mortality, Survival and Prevalence in Norway. Cancer Registry
of Norway, 2009: Oslo. http://www.kreftregisteret.no/Global/26-01-
2010%20Dok%20til%20web%20ferdig.pdf (visited 18 April 2011)
Galeone C, Tavani A, Pelucchi C, Turati F, Winn DM, Levi F, Yu G-P,
Morgenstern H, Kelsey K, Dal Maso L, Purdue MP, McClean M,
Talamini R, Hayes RB, Franceschi S, Schantz S, Zhang Z-F, Ferro G,
Chuang S-C, Boffetta P, La Vecchia C, Hashibe M (2010a) Coffee and tea
intake and risk of head and neck cancer: pooled analysis in the
International Head and Neck Cancer Epidemiology Consortium. Cancer
Epidemiol Biomarkers Prev 19: 1723–1736
Galeone C, Turati F, La Vecchia C, Tavani A (2010b) Coffee consumption
and risk of colorectal cancer: a meta-analysis of case–control studies.
Cancer Causes Control 21: 1949–1959
Jacobsen BK, Bjelke E, Kva ˚le G, Heuch I (1986) Coffee drinking, mortality,
and cancer incidence: Results from a Norwegian prospective study. JNCI
76: 823–831
Je Y, Liu W, Giovannucci E (2009) Coffee consumption and risk of
colorectal cancer: a systematic review and meta-analysis of prospective
cohort studies. Int J Cancer 124: 1662–1668
La Vecchia C, Ferraroni M, Negri E, D’Avanzo B, Decarli A, Levi F,
Franceschi S (1989) Coffee consumption and digestive tract cancers.
Cancer Res 49: 1049–1051
La Vecchia C, Tavani A (2007) Coffee and cancer risk: an update. Eur J
Cancer Prev 16: 385–389
La Vecchia C, Tavani A, Franceschi S, Levi F, Corrao G, Negri E (1997)
Epidemiology and prevention of oral cancer. Oral Oncol 33: 302–312
Naganuma T, Kuriyama S, Kakizaki M, Sone T, Nakaya N, Ohmori-
Matsuda K, Nishino Y, Fukao A, Tsuji I (2008) Coffee consumption and
the risk of oral, pharyngeal, and esophageal cancers in Japan. The Miyagi
Cohort Study. Am J Epidemiol 168: 1425–1432
Pintos J, Franco EL, Oliveira BV, Kowalski LP, Curado MP, Dewar R
(1994) Mate ´, coffee, and tea consumption and risk of cancers
of the upper aerodigestive tract in Southern Brazil. Epidemiology 5:
583–590
Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E,
Franceschi S, Levi F, Talamini R, La Vecchia C (2004) Risk factors for
oral and pharyngeal cancer in young adults. Oral Oncol 40: 207–213
Statistics Norway (2011) http://www.ssb.no/english/subjects/03/01/royk_en/
(visited 16 April 2011)
Stensvold I, Jacobsen BK (1994) Coffee and cancer: a prospective
study of 43,000 Norwegian men and women. Cancer Causes Control 5:
401–408
Tavani A, Bertuzzi M, Talamini R, Gallus S, Parpinel M, Franceschi S,
Levi F, La Vecchia C (2003) Coffee and tea intake and risk of oral,
pharyngeal and esophageal cancer. Oral Oncol 39: 695–700
Turati F, Galeone C, La Vecchia C, Garavello W, Tavani A (2011) Coffee and
cancers of the upper digestive and respiratory tracts: meta-analyses of
observational studies. Ann Oncol 22: 536–544
World Cancer Research Fund/American Institute for Cancer Research
(2007) Food, Nutrition, Physical Activity, and the Prevention of Cancer: a
Global Perspective. Washington DC: AICR
This work is licensed under the Creative Commons
Attribution-NonCommercial-Share Alike 3.0 Unported
License. To view a copy of this license, visit http://creativecommons.
org/licenses/by-nc-sa/3.0/
Coffee intake and oral–oesophageal cancer
A Tverdal et al
161
British Journal of Cancer (2011) 105(1), 157–161 & 2011 Cancer Research UK
E
p
i
d
e
m
i
o
l
o
g
y